Neşe Güney

431 total citations
20 papers, 347 citations indexed

About

Neşe Güney is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Neşe Güney has authored 20 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Neşe Güney's work include Ovarian cancer diagnosis and treatment (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Breast Cancer Treatment Studies (3 papers). Neşe Güney is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), Endometrial and Cervical Cancer Treatments (3 papers) and Breast Cancer Treatment Studies (3 papers). Neşe Güney collaborates with scholars based in Türkiye and United States. Neşe Güney's co-authors include Erkan Topuz, Duygu Derin, Hakan Çamlıca, Faruk Taş, Hilal Oğuz, Vildan Yasasever, Derya Duranyıldız, Adnan Aydıner, Yeşim Eralp and Mert Başaran and has published in prestigious journals such as Lung Cancer, European Journal of Obstetrics & Gynecology and Reproductive Biology and Investigational New Drugs.

In The Last Decade

Neşe Güney

20 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neşe Güney Türkiye 12 123 119 78 74 59 20 347
Mian He China 10 174 1.4× 175 1.5× 80 1.0× 76 1.0× 67 1.1× 21 472
Kazuhisa Kitami Japan 10 107 0.9× 102 0.9× 63 0.8× 76 1.0× 61 1.0× 40 292
Malee Warnnissorn Thailand 10 109 0.9× 135 1.1× 54 0.7× 38 0.5× 130 2.2× 32 371
Takahiro Ebata Japan 12 160 1.3× 152 1.3× 36 0.5× 102 1.4× 52 0.9× 34 404
Artit Jinawath Thailand 12 133 1.1× 221 1.9× 97 1.2× 68 0.9× 84 1.4× 32 451
C Villena-Heinsen Germany 14 132 1.1× 124 1.0× 55 0.7× 54 0.7× 67 1.1× 51 490
Špela Smrkolj Slovenia 12 123 1.0× 173 1.5× 37 0.5× 29 0.4× 107 1.8× 44 421
Hui‐Ping Chien Taiwan 12 141 1.1× 152 1.3× 83 1.1× 76 1.0× 57 1.0× 18 368
Sayaka Ueno Japan 10 85 0.7× 85 0.7× 62 0.8× 62 0.8× 39 0.7× 29 309
Yuichi Tsujimoto Japan 9 65 0.5× 129 1.1× 78 1.0× 108 1.5× 45 0.8× 38 314

Countries citing papers authored by Neşe Güney

Since Specialization
Citations

This map shows the geographic impact of Neşe Güney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neşe Güney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neşe Güney more than expected).

Fields of papers citing papers by Neşe Güney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neşe Güney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neşe Güney. The network helps show where Neşe Güney may publish in the future.

Co-authorship network of co-authors of Neşe Güney

This figure shows the co-authorship network connecting the top 25 collaborators of Neşe Güney. A scholar is included among the top collaborators of Neşe Güney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neşe Güney. Neşe Güney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taş, Faruk, Fatma Şen, Neşe Güney, Serkan Keskın, & Hakan Çamlıca. (2013). Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancer. Oncology Letters. 5(5). 1699–1703. 1 indexed citations
2.
Oğuz, Hilal, Derya Duranyıldız, Neşe Güney, Duygu Derin, & Vildan Yasasever. (2012). Utility of Serum and Urine uPAR Levels for Diagnosis of Breast Cancer. Asian Pacific Journal of Cancer Prevention. 13(6). 2887–2889. 9 indexed citations
3.
Çiçin, İrfan, Pınar Saip, Neşe Güney, et al.. (2009). Yolk sac tumours of the ovary: Evaluation of clinicopathological features and prognostic factors. European Journal of Obstetrics & Gynecology and Reproductive Biology. 146(2). 210–214. 34 indexed citations
4.
Güney, Neşe, Hilal Oğuz, Mert Başaran, et al.. (2009). Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma.. PubMed. 10(4). 669–74. 22 indexed citations
5.
Derin, Duygu, et al.. (2008). Ovarian Carcinoma with Simultaneous Breast and Rectum Metastases. Onkologie. 31(4). 200–202. 6 indexed citations
6.
Güney, Neşe, et al.. (2008). Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis. Medical Oncology. 26(2). 136–142. 9 indexed citations
7.
Taş, Faruk, Duygu Derin, Neşe Güney, Adnan Aydıner, & Erkan Topuz. (2008). Chemotherapy with pegylated liposomal doxorubicin and cisplatin in recurrent platinum-sensitive epithelial ovarian cancer. International Journal of Clinical Oncology. 13(4). 330–334. 7 indexed citations
8.
Taş, Faruk, Neşe Güney, Duygu Derin, Adnan Aydıner, & Erkan Topuz. (2008). A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer. International Journal of Clinical Oncology. 13(2). 156–160. 11 indexed citations
9.
Derin, Duygu, Yeşim Eralp, Yasemin Özlük, et al.. (2008). Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer. Cancer Investigation. 26(7). 671–679. 15 indexed citations
10.
Güney, Neşe, et al.. (2008). TA T1 Low and Intermediate Transitional Cell Carcinoma of the Bladder: Recurrence Rates and the Timing of Check Cystoscopies within the First Year. Urologia Internationalis. 80(2). 124–128. 11 indexed citations
11.
Derin, Duygu, Hilal Oğuz, Neşe Güney, et al.. (2007). Serum IL-8 and IL-12 levels in breast cancer. Medical Oncology. 24(2). 163–168. 50 indexed citations
12.
Özmen, Vahit, Ayhan Bılır, Neslihan Cabıoğlu, et al.. (2007). Is the thymidine labeling index a good prognostic marker in breast cancer?. World Journal of Surgical Oncology. 5(1). 93–93. 1 indexed citations
13.
Taş, Faruk, Duygu Derin, Neşe Güney, et al.. (2007). Addition of topotecan to standard cisplatin/etoposide combination in patients with extended stage small cell lung carcinoma. Lung Cancer. 57(1). 79–83. 3 indexed citations
14.
Taş, Faruk, Neşe Güney, Duygu Derin, et al.. (2007). Biweekly administration of gemcitabine and cisplatin chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer. Investigational New Drugs. 26(4). 363–368. 14 indexed citations
15.
Güney, Neşe, et al.. (2007). Malignant mesothelioma of the tunica vaginalis testis: a case report and review of the literature. Medical Oncology. 24(4). 449–452. 17 indexed citations
16.
Güney, Neşe, et al.. (2007). Primary Non-Hodgkin’s Lymphoma of the Rectum. Oncology Research and Treatment. 30(7). 385–387. 8 indexed citations
17.
Derin, Duygu, Hilal Oğuz, Neşe Güney, et al.. (2007). Serum levels of apoptosis biomarkers, survivin and TNF-alpha in nonsmall cell lung cancer. Lung Cancer. 59(2). 240–245. 60 indexed citations
18.
Güney, Neşe, Hilal Oğuz, Duygu Derin, et al.. (2007). Serum levels of intercellular adhesion molecule ICAM-1 and E-selectin in advanced stage non-small cell lung cancer. Medical Oncology. 25(2). 194–200. 28 indexed citations
19.
Güney, Neşe, Hilal Oğuz, Duygu Derin, et al.. (2006). Serum and Urine Survivin Levels in Breast Cancer. Medical Oncology. 23(3). 335–340. 25 indexed citations
20.
Çefle, Kıvanç, Neşe Güney, Şükrü Öztürk, et al.. (2006). Increased sister chromatid exchange frequency in young women with breast cancer and in their first-degree relatives. Cancer Genetics and Cytogenetics. 171(1). 65–67. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mian He Breakdown of academic impact, for papers by Kazuhisa Kitami Breakdown of academic impact, for papers by Malee Warnnissorn Breakdown of academic impact, for papers by Takahiro Ebata Breakdown of academic impact, for papers by Artit Jinawath Breakdown of academic impact, for papers by C Villena-Heinsen Breakdown of academic impact, for papers by Špela Smrkolj Breakdown of academic impact, for papers by Hui‐Ping Chien Breakdown of academic impact, for papers by Sayaka Ueno Breakdown of academic impact, for papers by Yuichi Tsujimoto
Rankless by CCL
2026